Janus Henderson Group PLC Organogenesis Holdings Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$1.89 - $2.93 $150,062 - $232,636
-79,398 Reduced 80.12%
19,706 $41,000
Q4 2022

Feb 14, 2023
SELL
$2.48 - $3.43 $18,411 - $25,464
-7,424 Reduced 6.97%
99,104 $266,000
Q3 2022

Nov 14, 2022
SELL
$3.14 - $6.43 $27,770 - $56,866
-8,844 Reduced 7.67%
106,528 $344,000
Q2 2022

Aug 15, 2022
BUY
$4.74 - $8.15 $546,863 - $940,281
115,372 New
115,372 $564,000

Others Institutions Holding ORGO

# of Institutions
118
Shares Held
64.3M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $437M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email